Fig. 5
From: Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
Clinical outcomes. Differences between the pulmonary fibrosis (PF)- and no PF-groups in length of stay (LOS) in the intensive care unit (ICU) in a the pre-DEXA-cohort and b the DEXA-cohort, and 60-day hospital mortality in c the pre-DEXA-cohort and d the DEXA-cohort. Kaplan–Meier curves are depicted and p-values were calculated using log-rank tests. For analysis of 60-day hospital mortality, patients who were discharged alive from the hospital or were still in the ICU or hospital on day 60 were censored at day 60. Numbers at risk are shown below graphs